Blog Tag: joint agreement

Strategic Partnership Announced between BioSig Technologies and Mayo Clinic

Strategic Partnership Announced between BioSig Technologies and Mayo Clinic

BioSig Technologies recently announced a ten-year strategic agreement with Mayo Clinic and Mayo Clinic Ventures. According to the press release, the agreement aims to advance clinical features of BioSig’s PURE EP System, which BioSig describes as a novel platform designed to obtain and display important clinical data during procedures that test the electrical activity of the heart, through close collaboration with leading Mayo electrophysiologists.  BioSig intends the collaboration to result in the development of future technologies.

Speaking of the agreement, Greg Cash, President and CEO of BioSig Technologies commented:

“Adding innovation and intellectual property to the equation should raise this collaboration to a whole new level, likely resulting in better diagnosis and treatment of complex arrhythmias in many patients.”

BioSig Technologies describes itself as a Minneapolis-based medical device company developing a platform for cardiac electrophysiology.  According to Yahoo! Finance, BioSig is publically traded over-the-counter and has a current market cap of about $36 million.

Mayo Clinic describes itself as a nonprofit organization committed to clinical practice, education, and research.

Mayo Clinic and Gentag, Inc. To Develop Wireless Sensors for Treatment of Obesity and Diabetes

Mayo Clinic and Gentag, Inc. have reached a joint intellectual property (IP) agreement to develop wearable biosensors designed to fight obesity and diabetes.  According to the press release, the agreement will allow certain patent rights and technologies of both Mayo Clinic and Gentag to be combined and commercialized.

The press release indicates that the two firms will also license third parties to combine Mayo Clinic’s clinical expertise with Gentag’s wearable skin patch technologies, and that more than 50 issued patents and technologies are being offered for licensing under the agreement.

The press release states that wearable patch sensors may be a “game-changer;”  the wearable patch sensors are the size of a small bandage, and include a sensor that communicates via a diabetes management system compatible with cell phones; and the system will allow researchers to monitor movement and develop treatments.

Additionally, the press release notes that Mayo’s Micro-Miniature Transceiver chip will be integrated with Gentag’s radar-responsive tag technology and integrated under the new license to develop a new type of communication chip that will combine Near Field Communication (NFC), Body Area Networks (BAN), as well as long-range wireless communication and geolocation.

The press release is available here.